TXA for SAH: Another swing and a miss for the wonder drug

Last week we covered TXA for epistaxis. The NoPAC study kept with the recent tradition in TXA papers and showed no benefit. This week, we are going to look at another TXA RCT, but this time for the management of subarachnoid hemorrhage (SAH). In case you were worried, this paper also stays within that tradition. … Continue reading TXA for SAH: Another swing and a miss for the wonder drug